Search research articles
Contact Us
Filters
Showing results (1-10 of 149) with videos related to
Page
of 15
Sort By:
Chest
|
October 16, 2002
CT virtual bronchoscopy for detecting Wegener granulomatosis
Ken-ichiro Inoue
Immunopharmacology and Immunotoxicology
|
September 27, 2013
Korean red ginseng for allergic rhinitis
Ken-ichiro Inoue
Environmental Health and Preventive Medicine
|
March 25, 2011
Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases
Ken-ichiro Inoue
Internal Medicine (Tokyo, Japan)
|
April 10, 2024
Tetramine in Patients with Myasthenia Gravis
Ken-Ichiro Inoue
Environmental Health Perspectives
|
July 2, 2011
Particulate matter-induced health effects: who is susceptible?
Ken-ichiro Inoue, Hirohisa Takano
The Journal of Allergy and Clinical Immunology
|
July 13, 2011
Particulate matter-induced hypersusceptibility to infection
Ken-ichiro Inoue, Hirohisa Takano
Thescientificworldjournal
|
February 22, 2011
Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation
Ken-Ichiro Inoue, Hirohisa Takano
Current Pharmaceutical Biotechnology
|
February 27, 2014
Metallothionein as a therapeutic molecular target against human diseases
Ken-ichiro Inoue, Masahiko Satoh
Expert Opinion on Investigational Drugs
|
April 7, 2010
Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders
Ken-ichiro Inoue, Hirohisa Takano
Current Pharmaceutical Biotechnology
|
April 18, 2013
Metallothionein as a negative regulator of pulmonary inflammation
Ken-ichiro Inoue, Hirohisa Takano
Page
of 15
Search research articles
Search
Showing results (1-10 of 149) with videos related to
Sort By:
Page
of 15
Chest
|
October 16, 2002
CT virtual bronchoscopy for detecting Wegener granulomatosis
Ken-ichiro Inoue
Immunopharmacology and Immunotoxicology
|
September 27, 2013
Korean red ginseng for allergic rhinitis
Ken-ichiro Inoue
Environmental Health and Preventive Medicine
|
March 25, 2011
Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases
Ken-ichiro Inoue
Internal Medicine (Tokyo, Japan)
|
April 10, 2024
Tetramine in Patients with Myasthenia Gravis
Ken-Ichiro Inoue
Environmental Health Perspectives
|
July 2, 2011
Particulate matter-induced health effects: who is susceptible?
Ken-ichiro Inoue, Hirohisa Takano
The Journal of Allergy and Clinical Immunology
|
July 13, 2011
Particulate matter-induced hypersusceptibility to infection
Ken-ichiro Inoue, Hirohisa Takano
Thescientificworldjournal
|
February 22, 2011
Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation
Ken-Ichiro Inoue, Hirohisa Takano
Current Pharmaceutical Biotechnology
|
February 27, 2014
Metallothionein as a therapeutic molecular target against human diseases
Ken-ichiro Inoue, Masahiko Satoh
Expert Opinion on Investigational Drugs
|
April 7, 2010
Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders
Ken-ichiro Inoue, Hirohisa Takano
Current Pharmaceutical Biotechnology
|
April 18, 2013
Metallothionein as a negative regulator of pulmonary inflammation
Ken-ichiro Inoue, Hirohisa Takano
Page
of 15